Literature DB >> 10902780

Failure of membrane targeting causes the functional defect of two mutant sodium iodide symporters.

J Pohlenz1, L Duprez, R E Weiss, G Vassart, S Refetoff, S Costagliola.   

Abstract

Molecular cloning of the sodium/iodide symporter (NIS) allowed identification of NIS gene mutations in patients with iodide trapping defect. Whereas various mutant human (h) NIS molecules display loss of function when expressed by transfection in mammalian cells, the precise mechanism(s) responsible for the functional abnormality of these proteins remains unknown. With the aim to explore these mechanisms in three natural hNIS mutants identified previously in patients with iodide trapping defect (Q267E, S515X, and C272X), we have prepared tools allowing direct measurement of the protein at its normal location in the plasma membrane. A COS-7 cell line was made by transfection that stably expressed high levels of wild-type hNIS. It was used to screen by flow cytometry monoclonal antibodies (mAbs) prepared from mice immunized against hNIS. Genetic immunization was performed by im injection of a wild-type hNIS complementary DNA construct, because this procedure has demonstrated the ability to produce antibodies recognizing native membrane proteins. One mAb that recognized an epitope of hNIS exposed on the extracellular side of the plasma membrane was selected for further studies. The epitope was localized on the sixth putative extracellular loop of the protein on the basis that the mAb did not recognize rat NIS, which exhibits major sequence differences in this segment. When this mAb was used to test by flow cytometry the expression of the three mutant hNIS proteins in transfected COS-7 cells, it detected similar amounts of wild-type, Q267E, and the S515X hNIS molecules in permeabilized cells. In contrast, only the wild-type hNIS was detected at the surface of nonpermeabilized cells. The C272X hNIS truncation mutant was not detected in intact or permeabilized cells. This is consistent with the absence of the mAb epitope from this mutant, which is expected to lack the sixth extracellular loop. Our data demonstrate that faulty membrane targeting is implicated in the mechanisms causing iodide trapping defect in the Q267E and S515X natural hNIS mutants.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10902780     DOI: 10.1210/jcem.85.7.6700

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  10 in total

1.  The iodide-transport-defect-causing mutation R124H: a δ-amino group at position 124 is critical for maturation and trafficking of the Na+/I- symporter.

Authors:  Viktoriya Paroder; Juan P Nicola; Christopher S Ginter; Nancy Carrasco
Journal:  J Cell Sci       Date:  2013-05-20       Impact factor: 5.285

2.  Asn441 plays a key role in folding and function of the Na+/I- symporter (NIS).

Authors:  Wenjing Li; Juan Pablo Nicola; L Mario Amzel; Nancy Carrasco
Journal:  FASEB J       Date:  2013-05-06       Impact factor: 5.191

Review 3.  Genetics of congenital hypothyroidism.

Authors:  S M Park; V K K Chatterjee
Journal:  J Med Genet       Date:  2005-05       Impact factor: 6.318

4.  Induction of thyroid gene expression and radioiodine uptake in thyroid cancer cells by targeting major signaling pathways.

Authors:  Peng Hou; Ermal Bojdani; Mingzhao Xing
Journal:  J Clin Endocrinol Metab       Date:  2009-12-11       Impact factor: 5.958

5.  Induction of thyroid gene expression and radioiodine uptake in melanoma cells: novel therapeutic implications.

Authors:  Peng Hou; Dingxie Liu; Meiju Ji; Zhi Liu; James M Engles; Richard L Wahl; Mingzhao Xing
Journal:  PLoS One       Date:  2009-07-10       Impact factor: 3.240

6.  The sodium iodide symporter is unlikely to be a thyroid/breast shared antigen.

Authors:  I Muller; L Zhang; C Giani; C M Dayan; M E Ludgate; F Grennan-Jones
Journal:  J Endocrinol Invest       Date:  2015-08-08       Impact factor: 4.256

Review 7.  [The sodium-iodide symporter. Pathophysiologic, diagnostic and therapeutic significance].

Authors:  C Spitzweg
Journal:  Internist (Berl)       Date:  2003-04       Impact factor: 0.743

8.  Do cell surface trafficking impairments account for variable cell surface sodium iodide symporter levels in breast cancer?

Authors:  S J Beyer; R E Jimenez; C L Shapiro; J Y Cho; S M Jhiang
Journal:  Breast Cancer Res Treat       Date:  2008-05-26       Impact factor: 4.872

9.  The G395R Mutation of the Sodium/Iodide Symporter (NIS) Gene in Patients with Dyshormonogenetic Congenital Hypothyroidism.

Authors:  Neda Mostofizade; Parvaneh Nikpour; Shaghayegh Haghjooy Javanmard; Modjtaba Emadi-Baygi; Hajar Miranzadeh-Mahabadi; Silva Hovsepian; Mahin Hashemipour
Journal:  Int J Prev Med       Date:  2013-01

10.  Diphenyleneiodonium, an inhibitor of NOXes and DUOXes, is also an iodide-specific transporter.

Authors:  C Massart; N Giusti; R Beauwens; J E Dumont; F Miot; J Van Sande
Journal:  FEBS Open Bio       Date:  2013-12-07       Impact factor: 2.693

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.